Home › Congenital Heart Defects › NCT06003023
Congenital Heart Disease Physical Activity Lifestyle Study V.2
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
Who can join
Ages 15 to 25 · All sexes
Full eligibility criteria
Inclusion Criteria: * Between the ages of 15-25 years * Diagnosed with moderate or complex structural CHD * Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU) Exclusion Criteria: * Unable to speak and read proficiently in English * Have a diagnosis of a genetic syndrome that impacts multiple organ systems * Have cognitive impairments that would interfere with completing study measures * Have been engaged in a formal exercise program within the past 6 months, * Have participated in the intervention arm of the previous CHD-PAL Study * Have undergone open-heart surgery or had a valve replacement in the last 3 months * Are unable to complete an exercise stress test using a treadmill * Are pregnant * Are prohibited to engage in at least moderate levels of physical activity by their cardiologist * Engage in \>30 minutes of moderate-to-vigorous physical activity per day, on average per accelerometer * Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia)
About the study
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors.
What is being tested
- Physical Activity Monitoring (behavioral)
- Tailored Exercise Prescription (behavioral)
- Healthy Lifestyle Education (behavioral)
- Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior (behavioral)
Sponsor: Jamie Jackson · Participants: 144 · Started: Jul 18, 2023
Contact the study team
- Jamie L Jackson, PhD · Phone: 6147223585
- Ruri Famelia, PhD · Phone: 6143553499
Official record on ClinicalTrials.gov — NCT06003023
Locations in the U.S.
| Ohio | Nationwide Children's Hospital, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.